Statin-intolerant patients need a different type of clinical trial, Rockefeller researchers say

Thursday, November 17, 2011 - 15:30 in Health & Medicine

Although only five percent of people in clinical trials report side effects from statin drugs, in practice the problem is far greater. Clinical trials need to better address the needs of statin-intolerant patients, Rockefeller researchers say. More »

Read the whole article on The Rockefeller University

More from The Rockefeller University

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net